Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Molecular tumour board: Where do we stand? What’s next?

Liquid biopsy for diagnostic and longitudinal tracking of metastatic patients

Date

29 Sep 2019

Session

Molecular tumour board: Where do we stand? What’s next?

Topics

Tumour Site

Colon and Rectal Cancer

Presenters

Giulia Siravegna

Authors

G. Siravegna

Author affiliations

  • Harvard Medical School, 2115 - Boston/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.